The pharmaceutical and biotech world has a reputation problem, and the practice of using social media to engender trust among stakeholders has been beset by its own recent challenges, as those social channels too have now fallen under public scrutiny.
This content was repurposed from the October 2018 Healthcare Issue of O'Dwyer's Magazine.
